The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Anna Meeuwisse. Photo: Patrik Hekkala

Anna Meeuwisse

Professor

Anna Meeuwisse. Photo: Patrik Hekkala

A Pill for the Ill? Patients’ Reports of Their Experience of the Medical Encounter in the Treatment of Depression

Author

  • Tommy Svensson
  • Anna Meeuwisse
  • Andreas Vilhelmsson

Summary, in English

Background



Starting in the 1960s, a broad-based patients’ rights movement began to question doctors’ paternalism and to demand disclosure of medical information, informed consent, and active participation by the individual in personal health care. According to scholars, these changes contributed to downplay the biomedical approach in favor of a more patient-oriented perspective. The Swedish non-profit organization Consumer Association for Medicines and Health (KILEN) has offered the possibility for consumers to report their perceptions and experiences from their use of medicines in order to strengthen consumer rights within the health care sector.



Methodology



In this paper, qualitative content analysis was used to analyze 181 KILEN consumer reports of adverse events from antidepressant medications in order to explore patients’ views of mental ill health symptoms and the doctor-patient interaction.



Principal Findings



Overall, the KILEN stories contained negative experiences of the patients’ medical encounters. Some reports indicated intense emotional outrage and strong feelings of abuse by the health care system. Many reports suggested that doctors and patients had very different accounts of the nature of the problems for which the patient was seeking help. Although patients sought help for problems like tiredness and sleeplessness (often with a personal crisis of some sort as a described cause), the treating doctor in most cases was exceptionally quick in both diagnosing depression and prescribing antidepressant treatment. When patients felt they were not being listened to, trust in the doctor was compromised. This was evident in the cases when the doctor tried to convince them to take part in medical treatment, sometimes by threatening to withdraw their sick-listing.



Conclusions



Overall, this study suggests that the dynamics happening in the medical encounter may still be highly affected by a medical dominance, instead of a patient-oriented perspective. This may contribute to a questionable medicalization and/or pharmaceuticalization of depression.

Department/s

  • School of Social Work
  • Social Medicine and Global Health

Publishing year

2013

Language

English

Publication/Series

PLoS ONE

Volume

8

Issue

6

Document type

Journal article

Publisher

Public Library of Science (PLoS)

Topic

  • Social Work

Keywords

  • treatment of depression
  • consumer reports of adverse events
  • KILEN
  • medical encounter
  • medicalization
  • pharmaceuticalization

Status

Published

Research group

  • Social Medicine and Global Health

ISBN/ISSN/Other

  • ISSN: 1932-6203